Table 2.
Demographics and clinical characteristics according to having had contact with a general practitioner during follow-up
| Contact with GP during follow-up | |||
|---|---|---|---|
| Yes: n = 200 (42%) | No: n = 275 (58%) | p-value | |
| Demographics | |||
| Age at time of questionnairea, M (SD) | 71.2 (7.6) | 71.3 (7.4) | 0.78 |
| Education levela | 0.76 | ||
| Low | 66 (34.0) | 99 (36.7) | |
| Intermediate | 76 (39.2) | 97 (35.9) | |
| High | 52 (26.8) | 74 (27.4) | |
| Marital Statusa | 0.07 | ||
| Partner | 179 (90.9) | 233 (85.3) | |
| No partner | 18 (9.1) | 40 (14.7) | |
| Number of comorbiditiesa | 0.84 | ||
| No comorbidities | 57 (29.1) | 83 (30.4) | |
| 1 comorbidity | 73 (37.2) | 105 (38.5) | |
| ≥ 2 comorbidities | 66 (33.7) | 85 (31.1) | |
| Preferring more contact with GP during follow-upa | 27 (35.5) | 49 (64.5) | 0.20 |
| Clinical characteristics | |||
| Primary treatmenta | < 0.001 | ||
| Surgery | 80 (40.0) | 73 (26.5) | |
| Radiotherapy | 25 (12.5) | 41 (14.9) | |
| Hormonal therapy | 29 (14.5) | 21 (7.6) | |
| Radiotherapy and hormonal therapy | 31 (15.5) | 48 (17.5) | |
| Active surveillance | 27 (13.5) | 63 (22.9) | |
| Watchful waiting | 4 (2.0) | 5 (1.8) | |
| Other/unknown | 4 (2.0) | 24 (8.7) | |
| Time since diagnosis in yearsa, M (range) | 4.4 (1.8–7.8) | 4.3 (1.8–8.1) | 0.39 |
| Tumor stagea | 0.003 | ||
| I | 31 (16.2) | 79 (31.2) | |
| II | 91 (47.6) | 105 (41.5) | |
| III | 44 (23.0) | 47 (18.6) | |
| IV | 25 (13.1) | 22 (8.7) | |
Notes: Percentages for a given variable do not sum up to 100% if the variable contained missing data
aMissing data: Age at time of questionnaire = 0; educational level = 11; marital status = 5; number of comorbidities = 6; preferring more contact with the GP during follow-up = 12; primary treatment = 0; time since diagnosis = 0; tumor stage = 31
Abbreviations: GP General Practitioner, M mean, SD standard deviation